Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Richens

Showing results (41-50 of 270) with videos related to

Pageof 27
Sort By:
British Journal of Clinical Pharmacology|August 1, 1979
Serum protein binding of valproic acid and its displacement by palmitic acid in vitroA Monks, A Richens
British Medical Journal (Clinical Research Ed.)|May 11, 1985
Treatment for teenagers with epilepsyM Espir, A Richens
Epilepsy Research|September 28, 2002
Clinical practice: antimalarial prophylaxis in patients with epilepsy [corrected]A Richens, C Andrews,
Clinical Pharmacokinetics|May 1, 1983
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administrationF Pisani, A Richens
Therapeutic Drug Monitoring|January 1, 1981
The ultrafree drug filters: need for closer evaluationE Perucca, A Richens
British Medical Journal|February 16, 1980
Phenobarbitone and epilepsyA Richens, J Oxley
British Medical Journal|March 22, 1980
Interaction between lithium and carbamazepineE Perucca, A Richens
Drugs|June 1, 1979
When should plasma drug levels be monitored?A Richens, S Warrington
Lancet (London, England)|January 27, 1973
Genetic systems in epileptic patientsD Tills, A Richens
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
Bioavailability and dissolution of proprietary and generic formulations of phenytoinI Soryal, A Richens
Pageof 27

Showing results (41-50 of 270) with videos related to

Sort By:
Pageof 27
British Journal of Clinical Pharmacology|August 1, 1979
Serum protein binding of valproic acid and its displacement by palmitic acid in vitroA Monks, A Richens
British Medical Journal (Clinical Research Ed.)|May 11, 1985
Treatment for teenagers with epilepsyM Espir, A Richens
Epilepsy Research|September 28, 2002
Clinical practice: antimalarial prophylaxis in patients with epilepsy [corrected]A Richens, C Andrews,
Clinical Pharmacokinetics|May 1, 1983
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administrationF Pisani, A Richens
Therapeutic Drug Monitoring|January 1, 1981
The ultrafree drug filters: need for closer evaluationE Perucca, A Richens
British Medical Journal|February 16, 1980
Phenobarbitone and epilepsyA Richens, J Oxley
British Medical Journal|March 22, 1980
Interaction between lithium and carbamazepineE Perucca, A Richens
Drugs|June 1, 1979
When should plasma drug levels be monitored?A Richens, S Warrington
Lancet (London, England)|January 27, 1973
Genetic systems in epileptic patientsD Tills, A Richens
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1992
Bioavailability and dissolution of proprietary and generic formulations of phenytoinI Soryal, A Richens
Pageof 27